Shanghai MicroPort EV MedTech Co. Ltd. A
Shanghai MicroPort EP MedTech Co., Ltd. engages in the research, development, production, and sale of medical devices in the field of electrophysiological interventional diagnosis and ablation therapy in China and internationally. The company offers cardiac ablation catheters, diagnostic catheters, and 3D navigation systems, as well as cryoablation solutions, such as ablation and diagnostic cathe… Read more
Shanghai MicroPort EV MedTech Co. Ltd. A (688351) - Net Assets
Latest net assets as of June 2025: CN¥1.78 Billion CNY
Based on the latest financial reports, Shanghai MicroPort EV MedTech Co. Ltd. A (688351) has net assets worth CN¥1.78 Billion CNY as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.95 Billion) and total liabilities (CN¥171.63 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.78 Billion |
| % of Total Assets | 91.2% |
| Annual Growth Rate | 31.72% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 78.92 |
Shanghai MicroPort EV MedTech Co. Ltd. A - Net Assets Trend (2020–2024)
This chart illustrates how Shanghai MicroPort EV MedTech Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Shanghai MicroPort EV MedTech Co. Ltd. A (2020–2024)
The table below shows the annual net assets of Shanghai MicroPort EV MedTech Co. Ltd. A from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.74 Billion | +3.36% |
| 2023-12-31 | CN¥1.69 Billion | +0.56% |
| 2022-12-31 | CN¥1.68 Billion | +184.18% |
| 2021-12-31 | CN¥589.63 Million | +1.91% |
| 2020-12-31 | CN¥578.57 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai MicroPort EV MedTech Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4716538455.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥2.17 Million | 0.12% |
| Other Components | CN¥1.74 Billion | 99.88% |
| Total Equity | CN¥1.74 Billion | 100.00% |
Shanghai MicroPort EV MedTech Co. Ltd. A Competitors by Market Cap
The table below lists competitors of Shanghai MicroPort EV MedTech Co. Ltd. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
FIRST BUSINESS F.S.DL-01
F:45D
|
$367.01 Million |
|
Kaiser China Holding Co Ltd
SHE:002425
|
$367.04 Million |
|
PostNL NV
AS:PNL
|
$367.05 Million |
|
GLOBAL MEDIC.REIT DL-001
F:3UN
|
$367.06 Million |
|
Forward Air Corporation
NASDAQ:FWRD
|
$366.87 Million |
|
Wavestone SA
F:2WSA
|
$366.72 Million |
|
Zhe Jiang Headman Machinery Co Ltd
SHG:688577
|
$366.65 Million |
|
Mattr Corp
PINK:MTTRF
|
$366.63 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai MicroPort EV MedTech Co. Ltd. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,685,058,043 to 1,741,735,971, a change of 56,677,928 (3.4%).
- Net income of 52,070,362 contributed positively to equity growth.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥52.07 Million | +2.99% |
| Other Changes | CN¥4.61 Million | +0.26% |
| Total Change | CN¥- | 3.36% |
Book Value vs Market Value Analysis
This analysis compares Shanghai MicroPort EV MedTech Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.32x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 16.17x to 6.32x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | CN¥1.45 | CN¥23.39 | x |
| 2021-12-31 | CN¥1.47 | CN¥23.39 | x |
| 2022-12-31 | CN¥3.56 | CN¥23.39 | x |
| 2023-12-31 | CN¥3.58 | CN¥23.39 | x |
| 2024-12-31 | CN¥3.70 | CN¥23.39 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai MicroPort EV MedTech Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.99%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.60%
- • Asset Turnover: 0.22x
- • Equity Multiplier: 1.09x
- Recent ROE (2.99%) is above the historical average (0.49%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.99% | 4.06% | 0.22x | 1.12x | CN¥-52.12 Million |
| 2021 | -2.03% | -6.30% | 0.28x | 1.13x | CN¥-70.94 Million |
| 2022 | 0.18% | 1.18% | 0.15x | 1.07x | CN¥-164.49 Million |
| 2023 | 0.34% | 1.73% | 0.18x | 1.08x | CN¥-162.82 Million |
| 2024 | 2.99% | 12.60% | 0.22x | 1.09x | CN¥-122.10 Million |
Industry Comparison
This section compares Shanghai MicroPort EV MedTech Co. Ltd. A's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,879,733,462
- Average return on equity (ROE) among peers: 24.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai MicroPort EV MedTech Co. Ltd. A (688351) | CN¥1.78 Billion | 0.99% | 0.10x | $366.87 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $792.82 Million | 25.77% | 0.17x | $318.98 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $482.51 Million | 20.84% | 0.32x | $2.79 Billion |
| Double Medical Technology Inc (002901) | $224.61 Million | 43.10% | 0.32x | $404.40 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $1.42 Million | 98.49% | 2.27x | $281.14 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $2.71 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $637.77 Million |
| Edan Instruments Inc (300206) | $1.26 Billion | 7.37% | 0.15x | $501.55 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $504.27 Million | 13.31% | 0.36x | $360.97 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $267.10 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $952.60 Million |